45
Participants
Start Date
August 31, 2013
Primary Completion Date
October 31, 2016
Study Completion Date
December 31, 2016
Minnelide™ 001
Minnelide™ will be given as a single agent intravenously as a 30-minute infusion daily x 21 days followed by a 7-day rest period. One cycle will equal 28 days.
University of Minnesota Masonic Cancer Clinic, Minneapolis
Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale
Lead Sponsor
Minneamrita Therapeutics LLC
INDUSTRY